Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS

US Patent 6489098 · Granted Dec 3, 2002

Estimated economic value: $810,000

Assignee

Inventors

View full patent text on Google Patents →